Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/bloodadvances.2020002657 http://scihub22266oqcxt.onion/10.1182/bloodadvances.2020002657 33057631!7594382!33057631     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Blood+Adv 2020 ; 4 (20): 4990-4993 Nephropedia Template TP {{tp|p=33057631|t=2020. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O |pdf=|usr=}}{{33057631}} gab.com Text Reduced prevalence of SARS-CoV-2 infection in ABO blood group O JO: Blood Adv http://www.kidney.de/pget.php?&tw=1&pmid=33057631 #FOAvip Identification of risk factors for contracting and developing serious illness following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount interest. Here, we performed a retrospective cohort analysis of all Danish individuals tested for SARS-CoV-2 between 27 February 2020 and 30 July 2020, with a known ABO and RhD blood group, to determine the influence of common blood groups on virus susceptibility. Distribution of blood groups was compared with data from nontested individuals. Participants (29% of whom were male) included 473 654 individuals tested for SARS-CoV-2 using real-time polymerase chain reaction (7422 positive and 466 232 negative) and 2 204 742 nontested individuals, accounting for approximately 38% of the total Danish population. Hospitalization and death from COVID-19, age, cardiovascular comorbidities, and job status were also collected for confirmed infected cases. ABO blood groups varied significantly between patients and the reference group, with only 38.41% (95% confidence interval [CI], 37.30-39.50) of the patients belonging to blood group O compared with 41.70% (95% CI, 41.60-41.80) in the controls, corresponding to a relative risk of 0.87 (95% CI, 0.83-0.91) for acquiring COVID-19. This study identifies ABO blood group as a risk factor for SARS-CoV-2 infection but not for hospitalization or death from COVID-19. Twit Text FOAVip Reduced prevalence of SARS-CoV-2 infection in ABO blood group O ????Blood Adv http://www.kidney.de/pget.php?&tw=1&pmid=33057631 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33057631 #FOAvip English Wikipedia <ref>{{Cite pmid|33057631}}</ref> Reduced prevalence of SARS-CoV-2 infection in ABO blood group O #MMPMID33057631 Barnkob MB; Pottegard A; Stovring H; Haunstrup TM; Homburg K; Larsen R; Hansen MB; Titlestad K; Aagaard B; Moller BK; Barington T Blood Adv 2020[Oct]; 4 (20): 4990-4993 PMID33057631show ga Identification of risk factors for contracting and developing serious illness following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount interest. Here, we performed a retrospective cohort analysis of all Danish individuals tested for SARS-CoV-2 between 27 February 2020 and 30 July 2020, with a known ABO and RhD blood group, to determine the influence of common blood groups on virus susceptibility. Distribution of blood groups was compared with data from nontested individuals. Participants (29% of whom were male) included 473 654 individuals tested for SARS-CoV-2 using real-time polymerase chain reaction (7422 positive and 466 232 negative) and 2 204 742 nontested individuals, accounting for approximately 38% of the total Danish population. Hospitalization and death from COVID-19, age, cardiovascular comorbidities, and job status were also collected for confirmed infected cases. ABO blood groups varied significantly between patients and the reference group, with only 38.41% (95% confidence interval [CI], 37.30-39.50) of the patients belonging to blood group O compared with 41.70% (95% CI, 41.60-41.80) in the controls, corresponding to a relative risk of 0.87 (95% CI, 0.83-0.91) for acquiring COVID-19. This study identifies ABO blood group as a risk factor for SARS-CoV-2 infection but not for hospitalization or death from COVID-19. |ABO Blood-Group System/*blood[MESH] |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/*blood/*epidemiology[MESH] |Denmark/epidemiology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Pandemics[MESH] |Pneumonia, Viral/*blood/*epidemiology[MESH] |Prevalence[MESH] |Protective Factors[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]Reduced prevalence of SARS-CoV-2 infection in ABO blood group O (epmc).pdf DeepDyve Pubget Overpricing